Factores de riesgo modificables de  enfermedad cerebrovascular en pacientes que han sufrido un ictus

Eliana Romina Meza Miranda

doi:10.35454/rncm.v4n4.317

Authors

Eliana Romina Meza Miranda Universidad Nacional de Asunción https://orcid.org/0000-0001-9791-8835

DOI:

https://doi.org/10.35454/rncm.v4n4.317

Keywords:

Stroke, Obesity, Dyslipidemia, Alcoholism, Smoking

Abstract

A cerebrovascular accident (CVA) is a neurological condition with significant impact on public health due to its high incidence, mortality and degree of disability. The aim of this study was to determine the frequency of modifiable risk factors in stroke patients at the Rigoberto Caballero Police Central Hospital.

Downloads

Download data is not yet available.

References

Feigin VL, Norrving B, Mensah GA. Global Burden of Stroke. Circ Res. 2017;120(3):439-448. doi: 10.1161/CIRCRESAHA.116.308413

Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al. Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 2016;15(9):913-924. doi: 10.1016/S1474-4422(16)30073-4

Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438-47. doi: 10.1016/S0140-6736(11)60393-0

Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586-613. doi: 10.1161/CIRCULATIONAHA.109.192703

O’Donnell M, Xavier D, Diener C, Sacco R, Lisheng L, Zhang H, et al. Rationale and design of INTERSTROKE: a global case-control study of risk factors for stroke. Neuroepidemiology. 2010;35(1):36-44. doi: 10.1159/000306058

Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke. 2007;38(6):1881-5. doi: 10.1161/STROKEAHA.106.475525

Coutts SB, Wein TH, Lindsay MP, Buck B, Cote R, Ellis P, et al. Canadian Stroke Best Practice Recommendations: secondary prevention of stroke guidelines, update 2014. Int J Stroke. 2015;10(3):282-91. doi: 10.1111/ijs.12439

Lichtman JH, Naert L, Allen NB, Watanabe E, Jones SB, Barry LC, et al. Use of antithrombotic medications among elderly ischemic stroke patients. Circ Cardiovasc Qual Outcomes. 2011;4(1):30-8. doi: 10.1161/CIRCOUTCOMES.109.850883

Razmara A, Ovbiagele B, Markovic D, Towfighi A. Patterns and Predictors of Blood Pressure Treatment, Control, and Outcomes among Stroke Survivors in the United States. J Stroke Cerebrovasc Dis. 2016;25(4):857-65. doi: 10.1016/j.jstrokecerebrovasdis.2015.12.027

Lin MP, Ovbiagele B, Markovic D, Towfighi A. “Life’s Simple 7” and Long-Term Mortality After Stroke. J Am Heart Assoc. 2015;4(11):e001470. doi: 10.1161/JAHA.114.001470

Heuschmann PU, Kircher J, Nowe T, Dittrich R, Reiner Z, Cifkova R, et al. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey. Eur J Prev Cardiol. 2015;22(10):1354-62. doi: 10.1177/2047487314546825

Redfern J, McKevitt C, Wolfe CD. Development of complex interventions in stroke care: a systematic review. Stroke. 2006;37(9):2410-9. doi: 10.1161/01.STR.0000237097.00342.a9

Ovbiagele B, Nguyen-Huynh MN. Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics. 2011;8(3):319-29. doi: 10.1007/s13311-011-0053-1

Chauhan G, Debette S. Genetic Risk Factors for Ischemic and Hemorrhagic Stroke. Curr Cardiol Rep. 2016;18(12):124. doi: 10.1007/s11886-016-0804-z

Obesity [internet]. Génova: World Health Organization; 2017 [citado el 10 de agosto de 2021]. Disponible en: http://www.who.int/features/factfiles/obesity/en/

Vicente VS, Cabral NL, Nagel V, Guesser VV, Safanelli J. Prevalence of obesity among stroke patients in five Brazilian cities: a cross-sectional study. Arq Neuropsiquiatr. 2018;76(6):367-372. doi: 10.1590/0004-282X20180053

Unas 2.600 muertes al año se asocian a la obesidad en Paraguay. [Internet]. Ministerio de Salud Pública y Bienestar Social; 2011 [consultado el 10 de agosto de 2021]. Disponible en: https://www.mspbs.gov.py/portal/18105/unas-2600-muertes-al-antildeo-se-asocian-a-la-obesidad-en-paraguay.html

Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586-613. doi: 10.1161/CIRCULATIONAHA.109.192703

Nam BH, Kannel WB, D’Agostino RB. Search for an optimal atherogenic lipid risk profile: from the Framingham Study. Am J Cardiol. 2006;97(3):372-5. doi: 10.1016/j.amjcard.2005.08.055

Suzuki K, Izumi M, Sakamoto T, Hayashi M. Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Cerebrovasc Dis. 2011;31(1):100-6. doi: 10.1159/000321506

Zhao W, An Z, Hong Y, Zhou G, Guo J, Zhang Y, et al. Low total cholesterol level is the independent predictor of poor outcomes in patients with acute ischemic stroke: a hospital-based prospective study. BMC Neurol. 2016;16:36. doi: 10.1186/s12883-016-0561-z

Olamoyegun MA, Akinlade AT, Fawale MB, Ogbera AO. Dyslipidaemia as a risk factor in the occurrence of stroke in Nigeria: prevalence and patterns. Pan Afr Med J. 2016;25:72. doi: 10.11604/pamj.2016.25.72.6496

Ji R, Liu G, Shen H, Wang Y, Li H, Peterson E, et al. Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population: data from China National Stroke Registry. Neurol Res. 2013;35(1):29-36. doi: 10.1179/1743132812Y.0000000107

Wang CJ, Wang YL, Li ZX, Wang YJ. The Management of LDL Cholesterol and Predictors of Goal Achievement in Stroke Patients in China: A Cross-Sectional Study. CNS Neurosci Ther. 2016;22(7):577-83. doi: 10.1111/cns.12543

Lee JS, Chang PY, Zhang Y, Kizer JR, Best LG, Howard BV. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study. Diabetes Care. 2017;40(4):529-537. doi: 10.2337/dc16-1958

Karapanayiotides T, Piechowski-Jozwiak B, van Melle G, Bogousslavsky J, Devuyst G. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology. 2004;62(9):1558-62. doi: 10.1212/01.wnl.0000123252.55688.05

Boehme AK, Esenwa C, Elkind MS. Stroke Risk Factors, Genetics, and Prevention. Circ Res. 2017;120(3):472-495. doi: 10.1161/CIRCRESAHA.116.308398

Chen R, Ovbiagele B, Feng W. Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes. Am J Med Sci. 2016;351(4):380-6. doi: 10.1016/j.amjms.2016.01.011

Kenmogne-Domning GH, Kamtchum-Tatuene J, Noumegni SR, Fokoua-Dongmo CM, Zafack JG, Noubiap JJ. Cardiac complications after stroke: protocol for a systematic review and meta-analysis. BMJ Open. 2018;8(5):e021416. doi: 10.1136/bmjopen-2017-021416

Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis. BMC Public Health. 2010;10:258. doi: 10.1186/1471-2458-10-258

Bonita R, Scragg R, Stewart A, Jackson R, Beaglehole R. Cigarette smoking and risk of premature stroke in men and women. Br Med J (Clin Res Ed). 1986;293(6538):6-8. doi: 10.1136/bmj.293.6538.6

Epstein KA, Viscoli CM, Spence JD, Young LH, Inzucchi SE, Gorman M, et al. Smoking cessation and outcome after ischemic stroke or TIA. Neurology. 2017;89(16):1723-1729. doi: 10.1212/WNL.0000000000004524

Putaala J, Haapaniemi E, Metso AJ, Metso TM, Artto V, Kaste M, et al. Recurrent ischemic events in young adults after first-ever ischemic stroke. Ann Neurol. 2010;68(5):661-71. doi: 10.1002/ana.22091

Rust R, Hofer AS, Schwab ME. Stroke Promotes Systemic Endothelial Inflammation and Atherosclerosis. Trends Mol Med. 2018;24(7):593-595. doi: 10.1016/j.molmed.2018.04.008